Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.81B |
| 2 |
Microsoft
MSFT
|
+$1.34B |
| 3 |
Apple
AAPL
|
+$1.25B |
| 4 |
Amazon
AMZN
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$480M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPLK
Splunk Inc
SPLK
|
+$373M |
| 2 |
Amgen
AMGN
|
+$204M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$180M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
+$160M |
| 5 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.47% |
| 2 | Financials | 12.91% |
| 3 | Healthcare | 12.22% |
| 4 | Consumer Discretionary | 10.6% |
| 5 | Industrials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCOV
3151
DELISTED
Brightcove, Inc.
BCOV
| $1.79M | ﹤0.01% |
922,348
+24,001
| +3% | +$52.7K |
|
|
ELEV
3152
DELISTED
Elevation Oncology
ELEV
| $1.79M | ﹤0.01% |
348,433
+118,297
| +51% | +$383K |
|
3153
Identive
INVE
$61.9M
| $1.79M | ﹤0.01% |
225,582
+3,865
| +2% | +$30.8K |
|
|
MURA
3154
DELISTED
Mural Oncology
MURA
| $1.79M | ﹤0.01% |
365,021
+8,654
| +2% | +$42K |
|
3155
Arq
ARQ
$89.3M
| $1.78M | ﹤0.01% |
275,313
+24,832
| +10% | +$92.6K |
|
3156
Duluth Holdings
DLTH
$159M
| $1.78M | ﹤0.01% |
363,061
-6,352
| -2% | -$31K |
|
3157
GeneDx Holdings
WGS
$2.3B
| $1.78M | ﹤0.01% |
194,401
+6,326
| +3% | +$38K |
|
3158
Century Casinos
CNTY
$34M
| $1.77M | ﹤0.01% |
561,608
+8,138
| +1% | +$27.4K |
|
3159
Mammoth Energy Services
TUSK
$163M
| $1.77M | ﹤0.01% |
487,355
+3,604
| +0.7% | +$13.6K |
|
3160
Enterprise Products Partners
EPD
$81.7B
| $1.77M | ﹤0.01% |
60,663
+936
| +2% | +$25.7K |
|
|
AUGX
3161
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $1.76M | ﹤0.01% |
430,765
+69,150
| +19% | +$309K |
|
|
AVDL
3162
DELISTED
Avadel Pharmaceuticals
AVDL
| $1.76M | ﹤0.01% |
104,227
+11,644
| +13% | +$173K |
|
3163
Star Bulk Carriers
SBLK
$3.22B
| $1.76M | ﹤0.01% |
73,651
| – | – |
|
3164
Immunocore
IMCR
$1.73B
| $1.76M | ﹤0.01% |
27,045
+1,016
| +4% | +$69.7K |
|
3165
Abeona Therapeutics
ABEO
$413M
| $1.75M | ﹤0.01% |
241,791
+22,406
| +10% | +$142K |
|
|
PVBC
3166
DELISTED
Provident Bancorp
PVBC
| $1.75M | ﹤0.01% |
191,945
+4,126
| +2% | +$41.4K |
|
|
AEVA
3167
Aeva Technologies
AEVA
$1.86B
| $1.75M | ﹤0.01% |
444,305
+83,583
| +23% | +$404K |
|
|
BGFV
3168
DELISTED
Big 5 Sporting Goods
BGFV
| $1.74M | ﹤0.01% |
495,527
+3,993
| +0.8% | +$19.2K |
|
|
FREE
3169
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
| $1.74M | ﹤0.01% |
361,087
-9,952
| -3% | -$42.4K |
|
|
GRSD
3170
Grandstand Limited Ordinary Shares
GRSD
$67M
| $1.74M | ﹤0.01% |
191,047
+2,735
| +1% | +$24.8K |
|
3171
Acrivon Therapeutics
ACRV
$74M
| $1.74M | ﹤0.01% |
242,846
+53,646
| +28% | +$249K |
|
3172
Enlight Renewable Energy
ENLT
$11.9B
| $1.72M | ﹤0.01% |
101,935
+6,169
| +6% | +$108K |
|
|
MITT
3173
TPG Mortgage Investment Trust
MITT
$225M
| $1.72M | ﹤0.01% |
280,238
-12,243
| -4% | -$75.2K |
|
3174
Cellebrite
CLBT
$3.99B
| $1.71M | ﹤0.01% |
154,753
+23,255
| +18% | +$237K |
|
3175
Prelude Therapeutics
PRLD
$390M
| $1.71M | ﹤0.01% |
361,632
+12,265
| +4% | +$47.7K |
|
Similar funds
Geode Capital Management's Q1 2024 Portfolio in Review
As of Q1 2024, Geode Capital Management held 4,738 positions worth $1.08T, up 13% from $956B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Geode Capital Management deployed $32.6B of net new capital in Q1 2024, opening 85 new positions and adding to 3,720 existing holdings. Its largest new stake was Solventum: 2,733,775 shares worth $0.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Amgen, an estimated $204M trimmed.
- Geode Capital Management's largest Q1 2024 buy was Solventum: 2,733,775 shares worth $0.
- Geode Capital Management added most to NVIDIA in Q1 2024, an estimated $1.81B increase.
- Geode Capital Management's biggest Q1 2024 reduction was Amgen, cutting an estimated $204M.
- Geode Capital Management fully exited Splunk Inc in Q1 2024, selling an estimated $373M.
- Geode Capital Management's ten largest holdings make up 28% of its $1.08T portfolio in Q1 2024.
- Geode Capital Management opened 85 new positions and closed 123 in Q1 2024.
- Geode Capital Management's portfolio value rose 13% quarter-over-quarter to $1.08T.
Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.